INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.560
-0.170 (-6.23%)
At close: Aug 1, 2025, 4:00 PM
2.600
+0.040 (1.56%)
After-hours: Aug 1, 2025, 7:48 PM EDT

INmune Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
68104203114182232
Upgrade
Market Cap Growth
-15.09%-48.97%78.35%-37.48%-21.41%270.69%
Upgrade
Enterprise Value
497317572112207
Upgrade
Last Close Price
2.564.6711.266.3410.2017.22
Upgrade
PS Ratio
1361.177396.101309.19304.221005.5321052.15
Upgrade
PB Ratio
1.983.235.321.892.275.98
Upgrade
P/TBV Ratio
5.176.659.742.612.8610.41
Upgrade
EV/Sales Ratio
981.375207.601127.89191.85619.1418856.25
Upgrade
Debt / Equity Ratio
0.010.010.270.260.190.00
Upgrade
Asset Turnover
0.0000.000.000.000
Upgrade
Quick Ratio
2.623.092.075.5518.4313.38
Upgrade
Current Ratio
2.643.142.165.9218.9513.51
Upgrade
Return on Equity (ROE)
-139.01%-119.83%-61.09%-38.91%-51.00%-38.80%
Upgrade
Return on Assets (ROA)
-61.33%-55.19%-26.78%-17.85%-25.92%-23.47%
Upgrade
Return on Capital (ROIC)
-77.49%-65.75%-29.98%-18.98%-27.12%-24.38%
Upgrade
Earnings Yield
-59.94%-40.64%-14.79%-23.99%-16.67%-5.22%
Upgrade
Buyback Yield / Dilution
-17.00%-10.92%-0.30%-11.14%-34.55%-16.70%
Upgrade
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q